CRSP - CRISPR Therapeutics AG

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts14111314
Avg. Estimate-0.63-1.13-0.25-4.82
Low Estimate-1.38-1.43-3.51-5.86
High Estimate0.23-0.890.91-3.67
Year Ago EPS-0.92-0.93-3.44-0.25
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts12101113
Avg. Estimate35.83M3.78M250.86M14.33M
Low EstimateN/AN/A212.99MN/A
High Estimate76.7M14.5M289.3M58.1M
Year Ago Sales115k328k3.12M250.86M
Sales Growth (year/est)31,056.50%1,052.40%7,930.10%-94.30%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.78-0.88-0.9-0.95
EPS Actual-0.92-0.93-1.012.4
Difference-0.14-0.05-0.113.35
Surprise %-17.90%-5.70%-12.20%352.60%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.63-1.13-0.25-4.82
7 Days Ago-0.63-1.13-0.25-4.82
30 Days Ago-0.68-1.13-0.33-4.77
60 Days Ago-1.03-0.98-3.86-4.17
90 Days Ago-1.03-0.98-3.86-4.17
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/A111
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/A1N/A1
Growth EstimatesCRSPIndustrySectorS&P 500
Current Qtr.31.50%N/AN/A0.01
Next Qtr.-21.50%N/AN/A0.06
Current Year92.70%N/AN/A-0.03
Next Year-1,828.00%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A